Research Site

Leawood, Kansas 66209

1 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small Cell Lung, Small Cell Lung Carcinoma Extensive Disease

Studies at this site

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer — Recruiting now
• Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN) — Running, not enrolling